-
Product Insights
![]()
Guangzhou Daily Press – Guangzhou Newspaper Culture Center – Guangdong
Equip yourself with the essential tools needed to make informed and profitable decisions with our Guangzhou Daily Press - Guangzhou Newspaper Culture Center - Guangdong report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story: Dive deep...
-
Thematic Analysis
New![]()
Publishing Sector Scorecard, Q3 2023 Update – Thematic Intelligence
GlobalData’s last quarterly update to the publishing sector scorecard stated: “Publishing companies must pre-empt how AI will transform the industry to avoid being blindsided.” One of the most immediate ways publishing companies have, and will continue to be impacted by AI involves AI-generated content.
-
Sector Analysis
New![]()
The US Open Tennis Championships, 2023 – Post Event Analysis
US Open Tennis Championships 2023 Report Overview The US Open Tennis Championships 2023 had an estimated annual sponsorship revenue of $149.15 million in 2023. The tournament had record-breaking single-session and daily attendance and 22 sponsorship deals with brands. The US Open Tennis Championships 2023 research report provides an analysis of the recent 2023 US Open Tennis Championships including a look at its sponsorship portfolio, broadcasters, attendance, and ticketing. The report includes a detailed overview of the key facts and events...
-
Product Insights
![]()
Contact Lenses Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies
Contact Lenses Pipeline Market Report Overview A contact lens is a corrective, cosmetic, or therapeutic lens that is placed on the cornea of the eye. The Contact Lenses pipeline market research report provides comprehensive information about the contact lens pipeline products with a comparative analysis of the products at various stages of development and information about the clinical trials that are in progress. Key Segments · Soft Contact Lenses · Rigid Gas Permeable Contact Lenses Key Territories · The US...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Insulin Glargine LA in Type 1 Diabetes (Juvenile Diabetes)
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.Insulin Glargine LA in Type 1 Diabetes (Juvenile Diabetes) Drug Details: Insulin glargine (Basalin) is a...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Insulin Glargine LA in Type 2 Diabetes
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.Insulin Glargine LA in Type 2 Diabetes Drug Details: Insulin glargine (Basalin) is a long-acting insulin...
-
Macroeconomic Analysis
New![]()
Mexico PESTLE Insights – A Macroeconomic Outlook Report
Mining, manufacturing, and utility activities contributed 26.2% to Mexico’s gross value added (GVA) in 2022, followed by wholesale, retail, and hotels business activities (23.6%), and financial intermediation, real estate, and business activities (16.5%). In nominal terms, the three sectors are expected to grow by 8.1%, 8.1%, and 7.9%, respectively, in 2023. Five major federal entities in Mexico generated approximately 36.2% of the country’s GDP and accounted for 27.5% of the country’s population as of 2022, according to GlobalData.
-
Company Profile
![]()
Daily Mail and General Trust Plc – Company Profile
Daily Mail and General Trust Plc (DMGT), a subsidiary of Rothermere Continuation Limited, is a provider of media services. The company manages a diverse, multinational portfolio of companies, which offer businesses and consumers with persuasive information, insight, analysis, events, news and entertainment services. It also provides risk and data solutions for the commercial mortgage-backed securities market and tools, and models for commercial real estate investors and lenders in the US. It provides organises event of B2B exhibitions and conferences in...
Add to Basket -
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Levetiracetam Er in Mild Cognitive Impairment
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.Levetiracetam Er in Mild Cognitive ImpairmentDrug Details: Levetiracetam ER (AGB-101) is under development for the treatment...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Amelenodor in Ulcerative Colitis
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.Amelenodor in Ulcerative ColitisDrug Details:Amelenodor (NX-13) is under development for the treatment of inflammatory bowel disease...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Cagrilintide in Type 2 Diabetes
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Cagrilintide in Type 2 Diabetes Drug Details: Cagrilintide is under development for the treatment...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Cagrilintide in Obesity
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Cagrilintide in Obesity Drug Details: Cagrilintide is under development for the treatment of obesity and...
-
Macroeconomic Analysis
New![]()
Singapore PESTLE Insights – A Macroeconomic Outlook Report
Financial intermediation, real estate and business activities contributed 24.7% to Singapore’s gross value added (GVA) in 2022, followed by mining, manufacturing and utilities activities (22.7%), and wholesale, retail and hotels activities (21.4%). In nominal terms, the three sectors are forecasted to grow by 6.6%, 7.8%, and 7.0%, respectively, in 2023. Singapore’s central region acts as hub for most of the financial and professional services firms. The western region is dominated by the port and water transport industry due to its...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – TNX-1900 in Social Anxiety Disorder (SAD/Social Phobia)
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. TNX-1900 in Social Anxiety Disorder (SAD/Social Phobia) Drug Details: Oxytocin (TI-001) is under development for...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – TNX-1900 in Obesity
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. TNX-1900 in Obesity Drug Details: Oxytocin (TI-001) is under development for the treatment of chronic...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Ondansetron Hydrochloride CR in Gastroenteritis
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Ondansetron Hydrochloride CR in Gastroenteritis Drug Details: Ondansetron hydrochloride (RHB-102, Bekinda) is under development for...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Ondansetron Hydrochloride CR in Gastritis
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Ondansetron Hydrochloride CR in Gastritis Drug Details: Ondansetron hydrochloride (RHB-102, Bekinda) is under development for...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – B-104 in Osteoporosis
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.B-104 in Osteoporosis Drug Details:Teriparatide acetate (ZP-PTH) daily formulation is under development for the treatment of...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – (Dexborneol + Edaravone) in Acute Ischemic Stroke
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. (Dexborneol + Edaravone) in Acute Ischemic Stroke Drug Details: Dexborneol and Edaravone (Sanbexin) is a...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – TNX-1900 in Migraine
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. TNX-1900 in Migraine Drug Details: Oxytocin (TI-001) is under development for the treatment of chronic...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.